An industry association has forced the medical schemes regulator to revoke Discovery’s permission to sell cheap primary health-care products, throwing a spanner in the life and health insurer’s plans to expand this part of its business.

While still a very small contributor to Discovery’s revenue stream, the number of lives covered by its primary care products has soared in the past two years, and so the recent ruling against it by the Council for Medical Schemes (CMS) appeal board is a blow...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.